Perspective - (2025) Volume 10, Issue 5
Received: 01-Sep-2025
Editor assigned: 03-Sep-2025
Reviewed: 17-Sep-2025
Revised: 22-Sep-2025
Published:
29-Sep-2025
, DOI: 10.37421/2472-100X.2025.10.362
Citation: Rossi, Isabella. ”Childhood Sleep Disorders: NeurologicalBasis and Management.” J Pediatr Neurol Med 10 (2025):362.
Copyright: © 2025 Rossi I. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,distribution and reproduction in any medium, provided the original author and source are credited.
Pediatric sleep disorders represent a complex and multifaceted challenge within the realm of child neurology, significantly impacting development, behavior, and overall quality of life. This review aims to synthesize current knowledge on the neurological underpinnings of common childhood sleep disorders, drawing from a comprehensive body of research. We begin by examining the fundamental neurological bases of these conditions, emphasizing the interplay of developmental changes in the brain and their contribution to sleep disturbances. The intricate neurobiological mechanisms underlying various pediatric sleep issues are explored, providing a foundational understanding for subsequent discussions. Specifically, the role of the hypocretin (orexin) system in narcolepsy is a critical area of focus, highlighting its dysfunction and genetic associations as key pathophysiological drivers. Furthermore, the neurodevelopmental perspective is crucial for understanding conditions like parasomnias, where disruptions in sleep architecture and maturational processes play a significant role. Similarly, pediatric insomnia is understood through its neurobiological roots, involving genetic predispositions, environmental influences, and disruptions in circadian and homeostatic sleep drives. The significant overlap between executive function deficits and sleep disturbances in conditions like ADHD is also a critical area of investigation, suggesting that impairments in cognitive control can directly affect sleep initiation and maintenance. The neurological correlates of restless legs syndrome (RLS) in children are explored, with potential links to dopaminergic pathways and iron deficiency being central to current understanding. The bidirectional relationship between epilepsy and sleep disorders in children is a particularly important consideration, given the reciprocal impact of seizures on sleep architecture and sleep deprivation on seizure threshold. Periodic limb movement disorder (PLMD) in pediatric populations also warrants careful neurological examination, with diagnostic accuracy being paramount to prevent misattribution of symptoms. Finally, the impact of sleep-disordered breathing (SDB), including obstructive sleep apnea (OSA), on neurological development and behavior in children is critically examined, underscoring the profound consequences of compromised respiratory function during sleep. The neurophysiological mechanisms and associated conditions of pediatric sleep bruxism are also investigated, highlighting its complex etiology and management [1].
The developing brain's intricate architecture and its role in regulating sleep-wake cycles are central to understanding pediatric sleep disorders. Early developmental trajectories, particularly in regions governing arousal and sleep, are profoundly influenced by genetic and environmental factors, shaping the susceptibility to conditions like insomnia, narcolepsy, and parasomnias. A multidisciplinary approach, integrating neurological insights with behavioral and pharmacological interventions, is increasingly recognized as essential for effective management [1].
Narcolepsy in children and adolescents is often linked to dysfunction within the hypocretin (orexin) system. This neuropeptide system plays a crucial role in regulating wakefulness, and its dysregulation, coupled with genetic predispositions, contributes significantly to the characteristic symptoms of narcolepsy, including excessive daytime sleepiness and cataplexy [2].
Parasomnias, such as night terrors and sleepwalking, are understood through a neurodevelopmental lens. These disorders are thought to arise from transient disruptions in sleep architecture during critical stages of brain maturation, highlighting the dynamic interplay between neural development and sleep regulation [3].
Pediatric insomnia is influenced by a complex interplay of neurobiological factors. Genetic vulnerabilities, environmental stressors, and disruptions in the body's natural circadian rhythms and sleep homeostatic drive all contribute to difficulties in initiating and maintaining sleep, necessitating a comprehensive understanding of these mechanisms for effective treatment [4].
The association between attention-deficit/hyperactivity disorder (ADHD) and sleep disturbances is deeply rooted in shared neurobiological pathways, particularly involving executive functions. Deficits in inhibitory control and working memory, core features of ADHD, can directly impair a child's ability to regulate sleep, leading to significant sleep problems [5].
Restless legs syndrome (RLS) in children is thought to involve the dopaminergic system and iron metabolism. Neurological pathways related to motor control and sensory processing are implicated, and iron deficiency is a frequently identified contributing factor to the characteristic urge to move the legs, particularly during periods of rest [6].
Epilepsy and sleep disorders in children share a complex and often bidirectional relationship. Seizures can disrupt normal sleep patterns, while sleep deprivation can, in turn, lower the seizure threshold, creating a challenging clinical scenario that requires integrated management strategies [7].
Periodic limb movement disorder (PLMD) in pediatric populations is primarily understood through its impact on sleep continuity. While distinct from RLS, PLMD involves involuntary limb movements during sleep that can fragment sleep and lead to daytime impairments, necessitating accurate diagnosis through polysomnography [8].
Sleep-disordered breathing (SDB), including obstructive sleep apnea (OSA), can have profound effects on neurological development in children. Intermittent hypoxia and sleep fragmentation caused by SDB can impair cognitive function, executive abilities, and behavioral regulation, underscoring the importance of addressing underlying causes [9].
Pediatric sleep bruxism, the involuntary grinding or clenching of teeth during sleep, is linked to neurophysiological mechanisms and is often associated with other sleep disorders such as sleep apnea and RLS. Its etiology is complex, involving a combination of central and peripheral factors, and its management requires a multidisciplinary approach [10].
The intricate neurological underpinnings of common childhood sleep disorders form the bedrock of effective diagnosis and treatment, necessitating a comprehensive, multidisciplinary approach. Developmental changes in the brain, particularly in regions governing sleep-wake regulation, are highlighted as key contributors to conditions like insomnia, narcolepsy, and parasomnias. This foundational understanding guides the integration of pharmacological interventions with behavioral therapies, addressing underlying neurological factors to improve patient outcomes [1].
Narcolepsy in pediatric populations is significantly influenced by dysfunction in the hypocretin (orexin) system. This neuropeptide's role in promoting wakefulness is critical, and its deficiency or improper signaling, often associated with genetic factors, is a primary cause of narcolepsy symptoms, requiring specialized diagnostic tools and therapeutic strategies [2].
Parasomnias, such as night terrors and sleepwalking, are viewed through a neurodevelopmental framework. These phenomena are believed to arise from transient disruptions in sleep architecture during critical periods of brain maturation, emphasizing the dynamic interplay between developmental processes and sleep regulation. Management focuses on safety and behavioral interventions, with pharmacological options reserved for severe cases [3].
Pediatric insomnia's neurobiological basis involves a complex interplay of genetic predispositions, environmental influences, and disruptions in circadian rhythms and sleep homeostatic drive. Understanding these interconnected factors is crucial for differentiating primary from secondary insomnia and for implementing evidence-based management, with cognitive behavioral therapy for insomnia (CBT-I) being a cornerstone of treatment [4].
The strong association between attention-deficit/hyperactivity disorder (ADHD) and sleep disturbances is attributed to shared neurobiological mechanisms, particularly within the realm of executive functions. Impairments in inhibitory control and working memory, characteristic of ADHD, can directly compromise a child's ability to regulate sleep initiation and maintenance, necessitating integrated treatment plans [5].
Restless legs syndrome (RLS) in children is explored through its neurological correlates, including the potential involvement of dopaminergic pathways and iron deficiency. The characteristic urge to move the legs during periods of rest is understood within the context of motor control and sensory processing networks, with iron supplementation and dopaminergic agents forming key treatment strategies [6].
The reciprocal relationship between epilepsy and sleep disorders in children is a critical clinical consideration. Seizures can profoundly disrupt sleep architecture, while conversely, sleep deprivation can lower seizure thresholds, creating a challenging clinical scenario. Management strategies aim to optimize antiepileptic drug regimens and improve sleep hygiene to mitigate this bidirectional impact [7].
Periodic limb movement disorder (PLMD) in pediatric populations is distinguished from RLS and is characterized by its impact on sleep continuity. Diagnostic methods, primarily polysomnography, are essential for identifying these movements, which can disrupt sleep and lead to daytime impairments. Treatment options include iron supplementation and dopaminergic agents [8].
Sleep-disordered breathing (SDB), including obstructive sleep apnea (OSA), has significant implications for neurological development and behavior in children. Intermittent hypoxia and sleep fragmentation associated with SDB can impair cognitive function and executive abilities, underscoring the need for timely identification and treatment of underlying causes like adenotonsillar hypertrophy [9].
Pediatric sleep bruxism is examined for its neurophysiological mechanisms and its frequent association with other sleep disorders, such as sleep apnea and RLS. Diagnostic challenges and the impact on dental health and sleep quality are discussed, with management approaches emphasizing a comprehensive, multidisciplinary strategy that may include oral appliances and behavioral interventions [10].
This collection of research explores the neurological basis and management of various childhood sleep disorders, including insomnia, narcolepsy, parasomnias, RLS, PLMD, sleep bruxism, and the impact of ADHD and epilepsy on sleep. It highlights the role of brain development, neurochemical systems like hypocretin and dopamine, and genetic factors in these conditions. Diagnostic tools such as polysomnography and multiple sleep latency testing are discussed, alongside treatment strategies ranging from behavioral therapies like CBT-I and scheduled awakenings to pharmacological interventions including stimulants, sodium oxybate, melatonin, and iron supplementation. The research emphasizes a multidisciplinary approach, addressing the bidirectional relationships between conditions like epilepsy and sleep, and the impact of sleep disturbances on cognitive function and overall well-being in children.
None
None
Journal of Pediatric Neurology and Medicine received 68 citations as per Google Scholar report
